We are proud to announce that our mcePharma's team has achieved a significant milestone in our journey.
We have been granted a patent in the European Union for our revolutionary dietary supplement, Neo Curcumin Supplement ODT.
The patent number is EP3400932, and it has territorial validity across Europe. The patent is titled "Mixture of Stabilised Biologically Available Curcumin for Orodispersible Formulations, Formulations of Biologically Available Curcumin, and an Orodispersible Tablet with Biologically Available Curcumin and Its Application."
This accomplishment marks a major breakthrough for us and validates the hard work and dedication we have put into developing this remarkable supplement. Neo Curcumin Supplement is designed to provide enhanced bioavailability and stability of curcumin, a potent natural compound known for its numerous health benefits.
The patented formulation allows for orodispersible (fast-dissolving) formulations, making it easier for individuals to incorporate curcumin into their daily routines. By ensuring the biologically available curcumin reaches its full potential, we aim to empower people to take control of their health and well-being.
We would like to express our heartfelt gratitude to our brilliant team of scientists, researchers, and all those who have contributed to this significant achievement. Their tireless efforts and unwavering commitment have brought us to this moment of triumph.
We firmly believe that this breakthrough will make a positive impact on countless lives, and we are excited to continue our mission of developing science-backed solutions for better health.
Looking for more information? Interested to distribute the product? Contact us!
